Loading

Commercializing SBIR/STTR Technologies

June 18, 2025
Breakout Session
Business Development and Investment
Won an SBIR/STTR grant from the NIH for your biomedical innovation? A new paradigm for inter-agency, industry, and venture capital collaboration is here to help commercialize it! Startups are 50% more likely to successfully commercialize their technology if they build partnerships early during development. But, finding the necessary partners is a major challenge for SBIR awardees and applicants. Panelists will discuss how two of the largest federal SBIR/STTR programs have joined forces with the private sector to solve this problem, through a new initiative called SBIR Partnering Platform. This interactive panel will discuss ways in which federal governments, industry partners, and private capital can come together to launch and scale critical technologies of the future.
Moderator
Rupak Doshi, PhD
CEO
OmniSync Incorporated
Speakers
Prathamesh Prabhudesai, MD, MBID
CEO and Co-Founder
SafeBVM Corp.
Fei Shen, PhD
Managing Director
Boehringer Ingelheim Venture Fund USA Inc.
Evan Unger, MD
Executive Chairman and Co-Founder
NuvOx Pharma

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS